Scientific breakthrough is almost always the product of collaboration and GTL places high value on partnering with companies and organizations whose strengths complement and augment our own. Over the last 7 years, we have forged many long-term collaborations with leading academic institutions and biotechnology and pharmaceutical companies to market  innovative new therapeutics and advance the care of patients confronting life-threatening diseases.